文献速递外周动脉疾病

仿生支架治疗腹股沟下外周动脉疾病:系统综述与Meta分析

Biomimetic Stents for Infrainguinal Peripheral Arterial Disease: Systematic Review and Meta-Analysis.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2023-11-04

该系统综述与Meta分析纳入37项研究共4480例患者,评估仿生支架治疗腹股沟下外周动脉疾病的效果。1年主要通畅率为81.4%(95%CI 78.7-83.9%),1年靶病变血运重建率为12.2%(95%CI 9.6-15.0%),证据确定性均为极低。仅1项研究报告1年支架断裂率为0.4%,证据确定性低。作者认为可考虑用于腹股沟下外周动脉疾病血管内血运重建,需随机对照试验确定临床与成本效果。

要点

  • 37项研究共4480例患者,1年主要通畅率81.4%,1年靶病变血运重建率12.2%。
  • 仅1项研究报告1年支架断裂率为0.4%。
  • 两项结局的GRADE证据确定性均为极低,支架断裂为低。

核心结论

  • 仿生支架用于腹股沟下外周动脉疾病可能与可接受的1年主要通畅率和靶病变血运重建率相关,1年支架断裂率接近可忽略。
  • 作者认为对于接受血管内血运重建的腹股沟下外周动脉疾病患者,应考虑使用仿生支架。
  • 作者指出需要随机对照试验来确定其临床和成本效果。

研究设计与样本

  • 系统综述与随机效应Meta分析,遵循PRISMA指南,PROSPERO注册号CRD42022385256。
  • 检索MEDLINE、Embase、CINAHL和Cochrane数据库。
  • 纳入37项研究(33项队列研究、2项病例系列、2项随机对照试验),共4480例参与者。
  • 34项研究包含Supera支架数据(占81.5%参与者),3项研究报告BioMimics 3D支架数据(占18.5%参与者)。
  • 采用Joanna Briggs Institute批判性评估工具评估研究质量,采用GRADE评估证据确定性。

主要发现

  • 33项研究1年随访的合并主要通畅率为81.4%(95%CI 78.7-83.9%),GRADE证据确定性为极低。
  • 18项研究1年随访的合并靶病变血运重建率为12.2%(95%CI 9.6-15.0%),GRADE证据确定性为极低。
  • 仅1项研究报告1年支架断裂率为0.4%,GRADE证据确定性为低。

临床怎么用

  • 作者认为对于接受血管内血运重建的腹股沟下外周动脉疾病患者,应考虑使用仿生支架。
  • 作者指出需要随机对照试验来确定仿生支架的临床和成本效果。

局限性

  • 两项主要结局(主要通畅率和靶病变血运重建率)的GRADE证据确定性均为极低。
  • 支架断裂率的证据确定性为低,且仅1项研究报告该结局。
  • 作者指出需要随机对照试验来确定临床和成本效果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Biomimetic stents are peripheral infrainguinal self expanding stents that mimic the anatomy of the vasculature and artery movement. They are indicated for use in infrainguinal arteries. This research aimed to synthesise all current evidence on the use of biomimetic stents as adjuncts for endovascular treatment of infrainguinal peripheral arterial disease (PAD), helping to guide clinical decision making. DATA SOURCES: MEDLINE, Embase, CINAHL and Cochrane databases. REVIEW METHODS: Random effects meta-analysis following PRISMA guidelines (PROSPERO registration CRD42022385256). Study quality was assessed using the Joanna Briggs Institute critical appraisal tools checklist, and certainty assessment through the Grading of Recommendations, Assessment, Development and Evaluation (GRADE). Endpoints included primary patency, target lesion revascularisation, stent fracture, secondary patency, and Death at one year. RESULTS: In total, 37 studies were included in the meta-analysis (33 cohort studies, two case series, and two randomised controlled trials [RCTs]), representing 4 480 participants. Of these, 34 studies included data on the Supera (81.5% of participants) and three studies reported data on the BioMimics 3D (18.5% of participants) stents. The pooled primary patency rate of 33 studies at one year follow up was 81.4% (95% confidence interval [CI] 78.7 - 83.9%), and the pooled target lesion revascularisation rate of 18 studies at one year was 12.2% (95% CI 9.6 - 15.0%). The certainty of evidence outcome rating as qualified by GRADE was very low for both. Only one study reported a positive stent fracture rate at one year follow up of 0.4% with a certainty of evidence outcome of low. CONCLUSION: Using biomimetic stents for infrainguinal PAD may be associated with acceptable one year primary patency and target lesion revascularisation rates, with a near negligible one year stent fracture rate. Their use should be considered in those presenting with infrainguinal PAD undergoing endovascular revascularisation. A RCT is necessary to determine their clinical and cost effectiveness.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Messeder SJ, López-Peña G, Pepper C, et al. Biomimetic Stents for Infrainguinal Peripheral Arterial Disease: Systematic Review and Meta-Analysis. Eur J Vasc Endovasc Surg. 2023. PMID: 37931680. doi:10.1016/j.ejvs.2023.11.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。